On February 9, 2023, the Centers for Medicare and Medicaid Services (CMS) issued initial program guidance related to the implementation of the Prescription Drug Inflation Rebate.
The Inflation Reduction Act of 2022 (IRA) establishes the Medicare Drug Price Negotiation Program ("Negotiation Program"), which permits the government to negotiate drug prices for certain high expenditure, single source Medicare Part B and Part D drugs.